Recall of Bronkaid Caplets Over Labeling

A voluntary recall of 56 lots of Bronkaid Caplets Dual Action Formula was initiated by Bayer HealthCare’s Consumer Care division after discovering that certain information was inadvertently omitted from the product carton label.

Bronkaid is prescribed for relief from bronchial congestion as well as mild intermittent asthma symptoms diagnosed by a physician.

PR Newswire reports that the oversight was discovered in a routine internal review where the company found that certain important information had been omitted from the Bronkaid Drug Facts labeling since early 2012. The recall is only for a labeling omission and the quality of the product is unaffected.

The recalled product was available in 24 caplets (UPC 300240537879) and 60 caplets (UPC 300240537855) and was sold only in the U.S. at retail outlets nationwide.

The information that was inadvertently omitted included advice to customers to stop using the product and consult their doctor in case their asthma worsened, they were finding it difficult to sleep, had a rapid heartbeat, seizure or nervousness, and tremors.

Consumers who have products from the recalled lots may continue using the product, if they are careful of the warning as well as the full drug fact labeling.

If you or a loved one has been harmed by an unsafe product, contact Sokolove Law for a free legal consultation and to find out if a product liability lawyer may be able to help you.

Tags: